Chronic prescription medication use in endurance runners: a cross-sectional study in 76,654 race entrants – SAFER XV

References

• Schwellnus MP. Premarathon evaluations: Is there a role for runner prerace medical screening and education to reduce the risk of medical complications? Curr Sports Med Rep. 2017 May/Jun;16(3):129–136.
   PubMed Web of Science ®Google Scholar
• Schwellnus M, Swanevelder S, Derman W, et al. Prerace medical screening and education reduce medical encounters in distance road races: SAFER VIII study in 153 208 race starters. Br J Sports Med. 2019;53(10):634–639.
   PubMed Web of Science ®Google Scholar
• Chugh SS, Weiss JB. Sudden cardiac death in the older athlete. J Am Colloid Cardiol. 2015;65(5):493–502.
   PubMed Web of Science ®Google Scholar
• Goodman JM, Burr JF, Banks L, et al. The acute risks of exercise in apparently healthy adults and relevance for prevention of cardiovascular events. Canad J Cardiol. 2016;32(4):523–532.
   PubMed Web of Science ®Google Scholar
• Day SM, Thompson PD. Cardiac risks associated with marathon running. Sports Health. 2010;2(4):301–306.
   PubMedGoogle Scholar
• Hew-Butler T, Rosner MH, Fowkes-Godek S, et al. Statement of the 3rd international exercise-associated hyponatremia consensus development conference, Carlsbad, California, 2015. Br J Sports Med. 2015;49(22):1432–1446.
   PubMed Web of Science ®Google Scholar
• Chlibkova D, Knechtle B, Rosemann T, et al. Rhabdomyolysis and exercise-associated hyponatremia in ultra-bikers and ultra-runners. J Int Soc Sports Nutr. 2015;12:29.
   PubMed Web of Science ®Google Scholar
• Pryor RR, Roth RN, Suyama J, et al. Exertional heat illness: emerging concepts and advances in prehospital care. Prehosp Disas Med. 2015;30(3):297–305.
   PubMed Web of Science ®Google Scholar
• Thompson PD, Franklin BA, Balady GJ, et al. Exercise and acute cardiovascular events placing the risks into perspective: a scientific statement from the American Heart association council on nutrition, physical activity, and metabolism and the council on clinical cardiology. Circulation. 2007 May 1;115(17):2358–2368.
   PubMed Web of Science ®Google Scholar
• Siscovick DS, Weiss NS, Fletcher RH, et al. Habitual vigorous exercise and primary cardiac arrest: effect of other risk factors on the relationship. J Chronic Dis. 1984;37(8):625–631.
   PubMedGoogle Scholar
• Schwabe K, Schwellnus M, Derman W, et al. Medical complications and deaths in 21 and 56 km road race runners: a 4-year prospective study in 65 865 runners–SAFER study I. Br J Sports Med. 2014;48(11):912–918.
   PubMed Web of Science ®Google Scholar
• Schwabe K, Schwellnus MP, Derman W, et al. Older females are at higher risk for medical complications during 21 km road race running: a prospective study in 39 511 race starters–SAFER study III. Br J Sports Med. 2014;48(11):891–897.
   PubMed Web of Science ®Google Scholar
• Schwabe K, Schwellnus MP, Derman W, et al. Less experience and running pace are potential risk factors for medical complications during a 56 km road running race: a prospective study in 26 354 race starters–SAFER study II. Br J Sports Med. 2014;48(11):905–911. .
   PubMed Web of Science ®Google Scholar
• Schwellnus M, Derman W. The quest to reduce the risk of adverse medical events in exercising individuals: introducing the SAFER (Strategies to reduce Adverse medical events For the ExerciseR) studies. Br J Sports Med. 2014;48(11):869–870.
   PubMed Web of Science ®Google Scholar
• Borjesson M, Urhausen A, Kouidi E, et al. Cardiovascular evaluation of middle-aged/senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Europ J Cardiovas Prev Rehabil. 2011;18(3):446–458.
   PubMedGoogle Scholar
• Bredin SS, Gledhill N, Jamnik VK, et al. PAR-Q+ and ePARmed-X+: new risk stratification and physical activity clearance strategy for physicians and patients alike. Canad Family Phys. 2013;59(3):273–277.
   PubMed Web of Science ®Google Scholar
• Maron BJ, Araújo CG, Thompson PD, et al. Recommendations for preparticipation screening and the assessment of cardiovascular disease in masters athletes: an advisory for healthcare professionals from the working groups of the world heart federation, the international federation of sports medicine, and the American heart association committee on exercise, cardiac rehabilitation, and prevention. Circulation. 2001;103(2):327–334.
   PubMed Web of Science ®Google Scholar
• Schwellnus M, Adami PE. Medical supervision of mass sporting events. In: Pressler A, Niebauer J, editors. Textbook of Sports and Exercise Cardiology. Switzerland: Springer Nature; 2020. p. 555–602.
   Google Scholar
• Brosnan MJ, Adami PE. Cardiovascular side effects of commonly prescribed medications and performance enhancing drugs and special considerations for the athlete. In: Pressler A, Niebauer J, editors. Textbook of Sports and Exercise Cardiology. Switzerland: Springer Nature; 2020. p. 517–530.
   Google Scholar
• duToit F, Schwellnus M, Wood P, et al. History of chronic disease is a novel intrinsic risk factor associated with gradual onset injuries in recreational road cyclists: a cross-sectional study in 21,824 cyclists - SAFER XIV. Phys Therap Sport. 2020;46:137–144.
   PubMed Web of Science ®Google Scholar
• Schwellnus MP, Swanevelder S, Jordaan E, et al. Underlying chronic disease, medication use, history of running injuries and being a more experienced runner are independent factors associated with exercise-associated muscle cramping: a cross-sectional study in 15778 distance runners. Clin JSport Med. 2018;28(3):289–298.
   Web of Science ®Google Scholar
• Aavikko A, Helenius I, Vasankari T, et al. Physician-prescribed medication use by the Finnish Paralympic and Olympic athletes. Clin J Sport Med. 2013;23(6):478–482.
   PubMed Web of Science ®Google Scholar
• Alaranta A, Alaranta H, Helenius I. Use of prescription drugs in athletes. Sports Med. 2008;38(6):449–463.
   PubMed Web of Science ®Google Scholar
• Alaranta A, Alaranta H, Heliövaara M, et al. Ample use of physician-prescribed medications in Finnish elite athletes. Int J Sports Med. 2006;27(11):919–925.
   PubMed Web of Science ®Google Scholar
• Corrigan B, Kazlauskas R. medication use in athletes selected for doping control at the Sydney Olympics (2000). Clin J of Sport Med. 2003;13(1):33–40.
   PubMed Web of Science ®Google Scholar
• Anderson SD, Fitch K, Perry CP, et al. Responses to bronchial challenge submitted for approval to use inhaled beta2-agonists before an event at the 2002 Winter Olympics. J Allerg Clin Immunol. 2003;111(1):45–50.
   PubMed Web of Science ®Google Scholar
• Anderson SD, Sue-Chu M, Perry CP, et al. Bronchial challenges in athletes applying to inhale a beta2-agonist at the 2004 Summer Olympics. J Allerg Clin Immunol. 2006;117(4):767–773.
   PubMed Web of Science ®Google Scholar
• Fitch KD. beta2-Agonists at the Olympic Games. Clin Rev Allerg Immunol. 2006;31(2–3):259–268.
   PubMed Web of Science ®Google Scholar
• Weiler JM, Layton T, Hunt M. Asthma in United States Olympic athletes who participated in the 1996 summer games.J Allerg Clin Immunol. 1998 ;102(5):722–726.
   PubMed Web of Science ®Google Scholar
• Weiler JM, Ryan EJ 3rd. Asthma in United States Olympic athletes who participated in the 1998 Olympic winter games. J Allerg Clin Immunol. 2000;106(2):267–271.
   PubMed Web of Science ®Google Scholar
• VOY RO. The U.S. Olympic Committee experience with exercise-induced bronchospasm, 1984. Med Sci Sports Exerc. 1986;18(3):328–330.
   PubMed Web of Science ®Google Scholar
• Tsitsimpikou C, Tsiokanos A, Tsarouhas K, et al. Medication use by athletes at the Athens 2004 summer Olympic games. Clin J Sport Med. 2009;19(1):33–38.
   PubMed Web of Science ®Google Scholar
• Alaranta A, Alaranta H, Palmu P, et al. Asthma medication in Finnish Olympic athletes: no signs of inhaled beta2-agonist overuse. Med Sci Sports Exerc. 2004;36(6):919–924.
   PubMed Web of Science ®Google Scholar
• Tsitsimpikou C, Jamurtas A, Fitch K, et al. Medication use by athletes during the Athens 2004 Paralympic Games. Br J Sports Med. 2009;43(13):1062–1066.
   PubMed Web of Science ®Google Scholar
• Tscholl P, Alonso JM, Dolle G, et al. The use of drugs and nutritional supplements in top-level track and field athletes. Amer J Sports Med. 2010;38(1):133–140.
   PubMed Web of Science ®Google Scholar
• Irewall T, Söderström L, Lindberg A, et al. High incidence rate of asthma among elite endurance athletes: a prospective 4-year survey. J Asthma. 2020;20:1–7.
   Google Scholar
• Nasman A, Irewall T, Hallmarker U, et al. Asthma and Asthma medication are common among recreational athletes participating in endurance sport Competitions. Canada Respi J. 2018;2018:3238546.
   PubMed Web of Science ®Google Scholar
• Kippelen P, Caillaud C, Coste O, et al. Asthma and exercise-induced bronchoconstriction in amateur endurance-trained athletes. Int J Sports Med. 2004;25(2):130–132.
   PubMed Web of Science ®Google Scholar
• Larsson K, Ohlsén P, Larsson L, et al. High prevalence of asthma in cross-country skiers. Br Med J. 1993;307(6915):1326–1329.
   PubMedGoogle Scholar
• Norqvist J, Eriksson L, Söderström L, et al. Self-reported physician-diagnosed asthma among Swedish adolescent, adult and former elite endurance athletes. J Asthma. 2015;52(10):1046–1053.
   PubMed Web of Science ®Google Scholar
• Randolph CC, Dreyfus D, Rundell KW, et al. Prevalence of allergy and asthma symptoms in recreational roadrunners. Med Sci Sports Exerc. 2006;38(12):2053–2057.
   PubMed Web of Science ®Google Scholar
• Shapero K, Deluca J, Contursi M, et al. cardiovascular risk and disease among masters endurance athletes: insights from the Boston MASTER (masters athletes survey to evaluate risk) initiative. Sports Med - Open. 2016;2(1):29.
   PubMedGoogle Scholar
• National Department of Health (NDoH), Statistics South Africa (Stats SA), Research SAM, et al. South Africa demographic and health survey 2016, Pretoria, National Department of Health. 2019.
   Google Scholar
• Lund T, Pedersen L, Larsson B, et al. Prevalence of asthma-like symptoms, asthma and its treatment in elite athletes. Scand J Med Sci Sports. 2009;19(2):174–178.
   PubMed Web of Science ®Google Scholar
• Hernelahti M, Kujala UM, Kaprio J, et al. Hypertension in master endurance athletes. Jf Hyperten. 1998;16(11):1573–1577. .
   PubMed Web of Science ®Google Scholar
• Machnik M, Sigmund G, Koch A, et al. Prevalence of antidepressants and biosimilars in elite sport. Drug Testing Anal. 2009;1(6):286–291.
   PubMed Web of Science ®Google Scholar
• Bandelow B, Michaelis S. Epidemiology of anxiety disorders in the 21st century. Dialogues Clin Neurosci. 2015;17(3):327–335.
   PubMed Web of Science ®Google Scholar
• Adamuz M. Management of Hypertension in Athletes. In: Wilson M, Drezner JA, Sharma S, editors. IOC Manual of Sports Cardiology. John Wiley & Sons, Ltd; 2017. p. 427–438.
   Google Scholar
• Deligiannis A, Björnstad H, Carre F, et al. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehab. 2006;13(5):687–694.
   PubMedGoogle Scholar
• Stöllberger C, Lutz W, Finsterer J. Heat-related side effects of neurological and non-neurological medication may increase heatwave fatalities. Eur J Neurol. 2009;16(7):879–882.
   PubMed Web of Science ®Google Scholar
• Szczepanik ME, Heled Y, Capacchione J, et al. Exertional rhabdomyolysis: identification and evaluation of the athlete at risk for recurrence. Curr Sports Med Rep. 2014;13(2):113–119. .
   PubMed Web of Science ®Google Scholar
• Coris EE, Ramirez AM, Van Durme DJ. Heat illness in athletes: the dangerous combination of heat, humidity and exercise. Sports Med. 2004;34(1):9–16.
   PubMed Web of Science ®Google Scholar
• Schwellnus MP, Derman EW, Noakes TD. Aetiology of skeletal muscle ‘cramps’ during exercise: a novel hypothesis. J Sports Sci. 1997;15(3):277–285.
   PubMed Web of Science ®Google Scholar
• Parisi L, Pierelli F, Amabile G, et al. Muscular cramps: proposals for a new classification. Acta Neurologica Scandi. 2003;107(3):176–186. .
   PubMed Web of Science ®Google Scholar
• Niedfeldt MW. Managing hypertension in athletes and physically active patients. Chichester, UK: American Fam Physic. 2002;66(3):445–452.
   PubMed Web of Science ®Google Scholar
• Hoogsteen J, Bennekers JH, van der Wall EE, et al. Recommendations and cardiological evaluation of athletes with arrhythmias: part 1. Nether Heart J. 2004;12(4):157–164.
   PubMedGoogle Scholar
• Casa DJ, Armstrong LE, Kenny GP, et al. Exertional heat stroke: new concepts regarding cause and care. Curr Sports Med Rep. 2012;11(3):115–123.
   PubMed Web of Science ®Google Scholar
• Behr ER, Roden D. Drug-induced arrhythmia: pharmacogenomic prescribing? Eur Heart J. 2013;34(2):89–95.
   PubMed Web of Science ®Google Scholar